Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
EDAC: ENCODE Data Analysis Center
Anionic Lipids Enriched at the Exportal of Streptococcus Pyogenes
Cancer and Leukemia Group B
Photochemistry & Strained Molecules
Pulse Steroid Therapy for Prevention of Bronchopulmonary Dysplasia
Recently added grants:
Combining experiments of man and nature to target human insulin resistance
Nanoparticle-mediated Histotripsy (NMH) for Noninvasive and Targeted Ablation of Metastatic Breast Cancer
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites
Transgenerational consequences of pre-conceptional and in utero exposure to real-life chemical mixtures on fertility and metabolic health
PepSAVI-MS for discovery of novel botanical antimicrobial peptides
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67187-3-0-1
Application #
7574868
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ University of Illinois at Chicago
$344,995
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Schraufnagel, Dean /
$292,732
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant